Notice: Power of Attorney | Jun 18, 2026 | PAPER | PETITIONER |
U.S. Patent No. 12,569,490 to Howerton | Jun 18, 2026 | EXHIBIT | PETITIONER |
Excerpts from the Prosecution History of the ‘490 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Grigoriadis PCT | Jun 18, 2026 | EXHIBIT | PETITIONER |
Final Written Decision, Paper 64 PGR2021-00088 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Grigoriadis | Jun 18, 2026 | EXHIBIT | PETITIONER |
Final Written Decision, Paper 62 PGR2022-00025 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Turcu 2016 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Crinecerfont_Prescribing Label | Jun 18, 2026 | EXHIBIT | PETITIONER |
Neurocrine Q4 2025 Earnings Release | Jun 18, 2026 | EXHIBIT | PETITIONER |
Speiser 2010 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Turcu_Auchus 2015 | Jun 18, 2026 | EXHIBIT | PETITIONER |
El Maouche 2017 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Merke_Bornstein 2005 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Speiser 2018 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Fahmy 2017 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Griebel 2002 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Gully 2002 | Jun 18, 2026 | EXHIBIT | PETITIONER |
European Pat. No. 3 784 233 to Howerton | Jun 18, 2026 | EXHIBIT | PETITIONER |
Merke_Auchus 2020 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Turcu_Auchus 2016 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Webb_Krone 2015 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Neurocrine March 20, 2021, Press Release | Jun 18, 2026 | EXHIBIT | PETITIONER |
Decision revoking EP 3 784 233 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Williams 2013 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Zorrilla_Koob 2010 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Director Review Request in PGR2021-00088, Paper 65 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Director Review Request in PGR2022-00025, Paper 63 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Compound Summary for CID 5282340 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Director Review Decision in PGR2021-00088, Paper 66 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Director Review Decision in PGR2022-00025, Paper 64 | Jun 18, 2026 | EXHIBIT | PETITIONER |
the ’908 patent | Jun 18, 2026 | EXHIBIT | PETITIONER |
the ’201 patent | Jun 18, 2026 | EXHIBIT | PETITIONER |
Zaarour_Bilateral Ovary Adrenal Rest Tumor | Jun 18, 2026 | EXHIBIT | PETITIONER |
Sarafoglou 2023 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Chen_Ovarian Adrenal Rest Tumors | Jun 18, 2026 | EXHIBIT | PETITIONER |
Sarafoglou 2021 | Jun 18, 2026 | EXHIBIT | PETITIONER |
the ’950 Patent | Jun 18, 2026 | EXHIBIT | PETITIONER |
Spruce Mar. 25, 2019, Press Release | Jun 18, 2026 | EXHIBIT | PETITIONER |
Spruce March 13, 2024, Press Release | Jun 18, 2026 | EXHIBIT | PETITIONER |
Spruce December 10, 2024, Press Release | Jun 18, 2026 | EXHIBIT | PETITIONER |
Turcu_Auchus 2015 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Mallappa_Merke | Jun 18, 2026 | EXHIBIT | PETITIONER |
Auchus 2022 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Claahsen-van der Grinten | Jun 18, 2026 | EXHIBIT | PETITIONER |
U.S. Pat. No. 11,304,950 Certificate of Correction | Jun 18, 2026 | EXHIBIT | PETITIONER |
PCT/US2019/029486 the PCT application | Jun 18, 2026 | EXHIBIT | PETITIONER |
Auchus 2024 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Sarafoglou et al. 2024 | Jun 18, 2026 | EXHIBIT | PETITIONER |
U.S. Provisional App. No. 62/663,951 | Jun 18, 2026 | EXHIBIT | PETITIONER |
U.S. Provisional App. No. 62/822,815 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Neurocrine July 1, 2024, Press Release | Jun 18, 2026 | EXHIBIT | PETITIONER |
Dec. 13, 2024, Neurocrine Press Release | Jun 18, 2026 | EXHIBIT | PETITIONER |
Compound Summary for CID 134694266 | Jun 18, 2026 | EXHIBIT | PETITIONER |
U.S. Pat. No. 6,586,456 to Fontaine | Jun 18, 2026 | EXHIBIT | PETITIONER |
17/081,694, Office Action | Jun 18, 2026 | EXHIBIT | PETITIONER |
Richard_The effect of long acting glucocorticoids | Jun 18, 2026 | EXHIBIT | PETITIONER |
Delfino_Testicular Adrenal Rest Tumors | Jun 18, 2026 | EXHIBIT | PETITIONER |
Yu_Clinical manifestations of testicular adrenal rest tumor | Jun 18, 2026 | EXHIBIT | PETITIONER |
Claahsen-van der Grinten | Jun 18, 2026 | EXHIBIT | PETITIONER |
Reisch _Testicular Adrenal Rest Tumors | Jun 18, 2026 | EXHIBIT | PETITIONER |
Mendes-dos-Santos | Jun 18, 2026 | EXHIBIT | PETITIONER |
Spruce Biosciences Clinical Study Report | Jun 18, 2026 | EXHIBIT | PETITIONER |
17/081,694 Allowance | Jun 18, 2026 | EXHIBIT | PETITIONER |
Smeets_Molecular Characterization | Jun 18, 2026 | EXHIBIT | PETITIONER |
Preliminary amendment 18/941,832 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Claim amendments 18/438,060 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Deussing_Chen | Jun 18, 2026 | EXHIBIT | PETITIONER |
FDA News Release_December 13, 2024 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Compound Summary for CID 11596613 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Compound Summary for CID 24758885 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Compound Summary for CID 24898976 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Compound Summary for CID 9821250 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Compound Summary for CID 9888194 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Compound Summary for CID 9884878 | Jun 18, 2026 | EXHIBIT | PETITIONER |
Compound Summary for CID 177990 | Jun 18, 2026 | EXHIBIT | PETITIONER |
NCT04457336 Spruce Biosciences | Jun 18, 2026 | EXHIBIT | PETITIONER |
Newfield_Crinecerfont | Jun 18, 2026 | EXHIBIT | PETITIONER |
PGR2025-00032, Paper 2 | Jun 18, 2026 | EXHIBIT | PETITIONER |
PGR2025-00032, Paper 8 | Jun 18, 2026 | EXHIBIT | PETITIONER |
List of claims for USP 12,569,490 as allowed | Jun 18, 2026 | EXHIBIT | PETITIONER |
Declaration of Ramesh Tharuvai, Ph.D. | Jun 18, 2026 | EXHIBIT | PETITIONER |
Merkatz_Inclusion of Women in Clinical Trials | Jun 18, 2026 | EXHIBIT | PETITIONER |
Declaration of Maya Lodish, M.D. | Jun 18, 2026 | EXHIBIT | PETITIONER |
Petition: as filed | Jun 18, 2026 | PAPER | PETITIONER |